(CHRS) Coherus Biosciences complete technical analysis [charts+indicators] | Buy/Sell Coherus Biosciences | (CHRS) share price targets
Complete technical analysis of Coherus Biosciences (CHRS) by charts plus indicators, forecast predictions and share price targets for Coherus Biosciences (CHRS)
Coherus Biosciences trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-18 View latest technical analysis
10 day averaged volume of Coherus Biosciences is 1195200
Date | Daily Closing Price | Open | High | Low | Volume |
18 Tue Jun 2024 | 1.62 | 1.63 | 1.70 | 1.61 | 0.581 times |
18 Tue Jun 2024 | 1.62 | 1.63 | 1.70 | 1.61 | 0.581 times |
17 Mon Jun 2024 | 1.64 | 1.69 | 1.69 | 1.60 | 1.553 times |
14 Fri Jun 2024 | 1.69 | 1.72 | 1.75 | 1.66 | 1.561 times |
13 Thu Jun 2024 | 1.78 | 1.83 | 1.83 | 1.74 | 0.596 times |
12 Wed Jun 2024 | 1.82 | 1.80 | 1.87 | 1.77 | 1.411 times |
11 Tue Jun 2024 | 1.73 | 1.74 | 1.77 | 1.70 | 0.853 times |
10 Mon Jun 2024 | 1.74 | 1.69 | 1.75 | 1.61 | 1.086 times |
07 Fri Jun 2024 | 1.69 | 1.72 | 1.75 | 1.68 | 0.757 times |
06 Thu Jun 2024 | 1.74 | 1.80 | 1.85 | 1.72 | 0.861 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 1.7, but if it comes above 1.7, then a intra day buy could be more profitable.
If you take a sell trade below 1.7, then use 1.7 as stoploss and 1.5 as target. However if you take a buy trade in stock , then use 1.7 as stoploss and 1.8 as target.
Share price targets for Coherus Biosciences (CHRS)
Target Type | Value |
Downside Target | 1.60 |
Upside Target | 1.68 |
Upside Target | 1.81 |
Upside Target | 1.87 |
Upside Target | 1.91 |
Upside Target | 1.93 |
Upside Target | 1.99 |
Upside Target | 2.05 |
Upside Target | 2.32 |
Upside Target | 2.61 |
Upside Target | 2.64 |
Upside Target | 2.87 |
Intraday share price targets for Coherus Biosciences (CHRS)
Target Type | Value |
Downside Intraday Target | 1.59 |
Downside Intraday Target | 1.55 |
Upside Intraday Target | 1.68 |
Upside Intraday Target | 1.73 |
Upside Intraday Target | 1.64 |
Weekly technical analysis of Coherus Biosciences (CHRS)
Date | Weekly Closing Price | Open | High | Low | Volume |
18 Tue Jun 2024 | 1.62 | 1.63 | 1.70 | 1.61 | 0.272 times |
18 Tue Jun 2024 | 1.62 | 1.69 | 1.70 | 1.60 | 0.387 times |
14 Fri Jun 2024 | 1.69 | 1.69 | 1.87 | 1.61 | 1.075 times |
07 Fri Jun 2024 | 1.69 | 1.84 | 1.87 | 1.68 | 1.118 times |
31 Fri May 2024 | 1.82 | 1.97 | 1.99 | 1.81 | 1.035 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Coherus Biosciences (CHRS)
Date | Monthly Closing Price | Open | High | Low | Volume |
18 Tue Jun 2024 | 1.62 | 1.84 | 1.87 | 1.60 | 0.439 times |
31 Fri May 2024 | 1.82 | 1.97 | 2.32 | 1.81 | 1.004 times |
30 Tue Apr 2024 | 1.96 | 2.40 | 2.61 | 1.91 | 0.593 times |
28 Thu Mar 2024 | 2.39 | 2.33 | 2.64 | 2.05 | 1.033 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Coherus Biosciences (CHRS)
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Coherus Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Coherus Biosciences in short term and the sell signal is strong.
Coherus Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Coherus Biosciences in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Coherus Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.71 and Coherus Biosciences (CHRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Coherus Biosciences (CHRS) stock. Volume based technical analysis of Coherus Biosciences (CHRS) stock is negative.
Coherus Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Coherus Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Coherus Biosciences in short term and the sell signal is strong.
Coherus Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Coherus Biosciences in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Coherus Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.71 and Coherus Biosciences (CHRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Coherus Biosciences (CHRS) stock. Volume based technical analysis of Coherus Biosciences (CHRS) stock is negative.
Coherus Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.